Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
22,422,337
-
Share change
-
+1,533,721
-
Total reported value
-
$291,927,279
-
Price per share
-
$13.02
-
Number of holders
-
84
-
Value change
-
+$16,321,496
-
Number of buys
-
50
-
Number of sells
-
28
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2015
As of 30 Jun 2015,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,422,337 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, BlackRock Fund Advisors, VANGUARD GROUP INC, FIRST MANHATTAN CO, OPPENHEIMER FUNDS INC, NORGES BANK, ARMISTICE CAPITAL, LLC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and Foundation Asset Management, LP.
This page lists
84
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.